| Literature DB >> 31043745 |
Carlos Silvestre-Roig1,2,3, Quinte Braster4,5,6, Kanin Wichapong7, Ernest Y Lee8, Jean Marie Teulon9, Nihel Berrebeh9, Janine Winter4, José M Adrover10, Giancarlo Santiago Santos8, Alexander Froese11,12, Patricia Lemnitzer4, Almudena Ortega-Gómez4,6, Raphael Chevre4, Julian Marschner13, Ariane Schumski4,6, Carla Winter4,6, Laura Perez-Olivares4, Chang Pan4, Nicole Paulin4, Tom Schoufour5, Helene Hartwig4,5, Silvia González-Ramos4, Frits Kamp14, Remco T A Megens4,15, Kerri A Mowen16, Matthias Gunzer17, Lars Maegdefessel6,18,19, Tilman Hackeng7, Esther Lutgens4,20, Mat Daemen5, Julia von Blume21, Hans-Joachim Anders13, Viacheslav O Nikolaev11,12, Jean-Luc Pellequer9, Christian Weber4,6,7, Andrés Hidalgo4,10, Gerry A F Nicolaes7, Gerard C L Wong8, Oliver Soehnlein22,23,24,25,26.
Abstract
The perpetuation of inflammation is an important pathophysiological contributor to the global medical burden. Chronic inflammation is promoted by non-programmed cell death1,2; however, how inflammation is instigated, its cellular and molecular mediators, and its therapeutic value are poorly defined. Here we use mouse models of atherosclerosis-a major underlying cause of mortality worldwide-to demonstrate that extracellular histone H4-mediated membrane lysis of smooth muscle cells (SMCs) triggers arterial tissue damage and inflammation. We show that activated lesional SMCs attract neutrophils, triggering the ejection of neutrophil extracellular traps that contain nuclear proteins. Among them, histone H4 binds to and lyses SMCs, leading to the destabilization of plaques; conversely, the neutralization of histone H4 prevents cell death of SMCs and stabilizes atherosclerotic lesions. Our data identify a form of cell death found at the core of chronic vascular disease that is instigated by leukocytes and can be targeted therapeutically.Entities:
Mesh:
Substances:
Year: 2019 PMID: 31043745 PMCID: PMC6716525 DOI: 10.1038/s41586-019-1167-6
Source DB: PubMed Journal: Nature ISSN: 0028-0836 Impact factor: 49.962